REFERENCES
1. Berger L. L’sesthesion Euriepitheliome olfactif (Olfactory neuroblastoma). Bull Assoc Fr Etud Cancer 1924;13:410-20. Available from: https://api.semanticscholar.org/CorpusID:73936422. [Last accessed on 31 Oct 2024]
2. Ferlito A, Rinaldo A, Rhys-Evans PH. Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck. Laryngoscope 2003;113:1935-8.
3. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683-706.
4. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001;2:683-90.
5. Svane-Knudsen V, Jørgensen KE, Hansen O, Lindgren A, Marker P. Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology 1998;36:12-4.
6. Kuan EC, Nasser HB, Carey RM, et al. A population-based analysis of nodal metastases in esthesioneuroblastomas of the sinonasal tract. Laryngoscope 2019;129:1025-9.
7. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976;37:1571-6.
8. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992;102:843-9.
9. Rimmer J, Lund VJ, Beale T, Wei WI, Howard D. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope 2014;124:1542-9.
10. Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget 2016;7:52584-96.
11. Nichols AC, Chan AW, Curry WT, Barker FG, Deschler DG, Lin DT. Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base 2008;18:327-37.
12. Oskouian RJ Jr, Jane JA Sr, Dumont AS, Sheehan JM, Laurent JJ, Levine PA. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus 2002;12:e4.
13. Wu K, Avila SA, Bhuyan R, et al. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature. Orbit 2022;41:1-14.
14. Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am 2013;24:51-65.
16. Touihmi S, Horrane I, Rkain I. An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report. Ann Med Surg 2023;85:2029-33.
17. Zhong W, Wang C, Ye W, Wu D. Primary olfactory neuroblastoma of the nasopharynx: a case report. Ear Nose Throat J 2023;102:NP19-23.
18. Kumaria A, Jahshan F, Paine S, Reed M, Ingale HA, Ramakrishnan Y. Olfactory neuroblastoma limited to sphenoid sinus. Br J Neurosurg 2023;37:237-40.
19. Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesioneuroblastoma: results and outcomes of a single institution’s experience. Skull Base 2009;19:133-40.
20. Koo BK, An JH, Jeon KH, et al. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J 2008;55:469-75.
21. Sharma S, Lasheen W, Walsh D. Paraneoplastic refractory hypercalcemia due to advanced metastatic esthesioneuroblastoma. Rhinology 2008;46:153-5.
22. Gabbay U, Leider-Trejo L, Marshak G, Gabbay M, Fliss DM. A case and a series of published cases of esthesioneuroblastoma (ENB) in which long-standing paraneoplastic SIADH had preceded ENB diagnosis. Ear Nose Throat J 2013;92:E6.
23. Kunc M, Gabrych A, Czapiewski P, Sworczak K. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol 2015;19:6-16.
24. von Zeidler SV, Guidi R, Alencar Rde C, et al. Atypical esthesioneuroblastoma invading oral cavity: a case report and review of the literature. Diagn Pathol 2014;9:10.
25. Banuchi VE, Dooley L, Lee NY, et al. Patterns of regional and distant metastasis in esthesioneuroblastoma. Laryngoscope 2016;126:1556-61.
26. Zanation AM, Ferlito A, Rinaldo A, et al. When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. Eur Arch Otorhinolaryngol 2010;267:1667-71.
27. Fiani B, Quadri SA, Cathel A, et al. Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options. World Neurosurg 2019;126:194-211.
28. Roytman M, Tassler AB, Kacker A, et al. [68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases. J Neurosurg Case Lessons 2021;1:CASE2058.
29. Chadha S, Pannu KK. Esthesioneuroblastoma a case report. Indian J Otolaryngol Head Neck Surg 2011;63:44-6.
30. Mozaffari K, Pradhan A, Yang I, Patel K, Vivas AC. Metastatic esthesioneuroblastoma recurrence after 19 years of remission: a systematic review with case illustration. J Neurol Sci 2022;442:120406.
31. Pickuth D, Heywang-Köbrunner SH. Imaging of recurrent esthesioneuroblastoma. Br J Radiol 1999;72:1052-7.
32. Dublin AB, Bobinski M. Imaging characteristics of olfactory neuroblastoma (Esthesioneuroblastoma). J Neurol Surg B Skull Base 2016;77:1-5.
33. Rostomily RC, Elias M, Deng M, et al. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Head Neck 2006;28:305-12.
34. Vuncannon JR, Wise SK. Hemostasis in endoscopic sinus and skull base surgery. Curr Opin Otolaryngol Head Neck Surg 2023;31:33-8.
35. Ali MF. Transcranial Doppler ultrasonography (uses, limitations, and potentials): a review article. Egypt J Neurosurg 2021;36:114.
36. Dixon L, Lim A, Grech-Sollars M, Nandi D, Camp S. Intraoperative ultrasound in brain tumor surgery: a review and implementation guide. Neurosurg Rev 2022;45:2503-15.
37. Prada F, Del Bene M, Casali C, et al. Intraoperative navigated angiosonography for skull base tumor surgery. World Neurosurg 2015;84:1699-707.
38. Tang H, Sun H, Xie L, et al. Intraoperative ultrasound assistance in resection of intracranial meningiomas. Chin J Cancer Res 2013;25:339-45.
39. Jarmula J, de Andrade EJ, Kshettry VR, Recinos PF. The current state of visualization techniques in endoscopic skull base surgery. Brain Sci 2022;12:1337.
40. AlQahtani A, Castelnuovo P, Nicolai P, Prevedello DM, Locatelli D, Carrau RL. Injury of the internal carotid artery during endoscopic skull base surgery: prevention and management protocol. Otolaryngol Clin North Am 2016;49:237-52.
41. Josephson CB, White PM, Krishan A, Al-Shahi Salman R. Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage. Cochrane Database Syst Rev 2014;2014:CD009372.
42. Raabe A, Beck J, Gerlach R, Zimmermann M, Seifert V. Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow. Neurosurgery 2003;52:132-9; discussion 139.
43. Suero Molina E, Bruneau M, Reuter G, et al; EANS Skull Base Section. Fluorescence guidance in skull base surgery: applications and limitations - A systematic review. Brain Spine 2024;4:103328.
44. Shahein M, Prevedello DM, Beaumont TL, et al. The role of indocyanine green fluorescence in endoscopic endonasal skull base surgery and its imaging correlations. J Neurosurg 2021;135:923-33.
45. Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol 2009;16:322-31.
46. Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol 2022;16:123-42.
47. Mehta GU, Raza SM, Su SY, Hanna EY, DeMonte F. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol 2020;150:367-75.
48. Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 2015;9:51-9.
49. Ziai H, Yu E, Weinreb I, et al. Regional recurrences and Hyams grade in esthesioneuroblastoma. J Neurol Surg B Skull Base 2021;82:608-14.
50. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-14; discussion 714-5.
52. Finlay JB, Abi Hachem R, Jang DW, Osazuwa-Peters N, Goldstein BJ. Deconstructing olfactory epithelium developmental pathways in olfactory neuroblastoma. Cancer Res Commun 2023;3:980-90.
53. Lechner M, Takahashi Y, Turri-Zanoni M, et al. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer 2022;162:221-36.
54. Walch C, Stammberger H, Anderhuber W, Unger F, Köle W, Feichtinger K. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000;110:635-40.
55. Shah JP, Kraus DH, Bilsky MH, Gutin PH, Harrison LH, Strong EW. Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 1997;123:1312-7.
56. Levine PA, Gallagher R, Cantrell RW. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999;109:1539-43.
57. Kuan EC, Wang EW, Adappa ND, et al. International consensus statement on allergy and rhinology: sinonasal tumors. Int Forum Allergy Rhinol 2024;14:149-608.
58. Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol 2019;9:S145-365.
59. Unger F, Haselsberger K, Walch C, Stammberger H, Papaefthymiou G. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir 2005;147:595-601; discussion 601.
60. Gallia GL, Reh DD, Salmasi V, Blitz AM, Koch W, Ishii M. Endonasal endoscopic resection of esthesioneuroblastoma: the Johns Hopkins Hospital experience and review of the literature. Neurosurg Rev 2011;34:465-75.
61. Lund V, Howard DJ, Wei WI. Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol 2007;21:89-94.
62. Castelnuovo P, Bignami M, Delù G, Battaglia P, Bignardi M, Dallan I. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck 2007;29:845-50.
63. Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol 2008;22:308-16.
64. Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg 2007;136:104-7.
65. Folbe A, Herzallah I, Duvvuri U, et al. Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy 2009;23:91-4.
66. Fu TS, Monteiro E, Muhanna N, Goldstein DP, de Almeida JR. Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: a systematic review and individual participant data meta-analysis. Head Neck 2016;38 Suppl 1:E2306-16.
67. Spielman DB, Liebowitz A, Grewal M, et al. Exclusively endoscopic surgical resection of esthesioneuroblastoma: a systematic review. World J Otorhinolaryngol Head Neck Surg 2022;8:66-72.
68. Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg 2009;135:1219-24.
69. Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with anterior craniofacial and combined cranionasal resection of esthesioneuroblastomas. World Neurosurg 2013;80:148-59.
70. Barinsky GL, Azmy MC, Kilic S, et al. Comparison of open and endoscopic approaches in the resection of esthesioneuroblastoma. Ann Otol Rhinol Laryngol 2021;130:136-41.
71. Hannan CJ, Kelleher E, Javadpour M. Methods of skull base repair following endoscopic endonasal tumor resection: a review. Front Oncol 2020;10:1614.
72. Snyderman CH, Wang EW, Zenonos GA, Gardner PA. Reconstruction after endoscopic surgery for skull base malignancies. J Neurooncol 2020;150:463-8.
73. Adel M, Chang KP. Using a nasoseptal flap for the reconstruction of osteoradionecrosis in nasopharyngeal carcinoma: a case report. J Otolaryngol Head Neck Surg 2016;45:27.
74. Harvey RJ, Parmar P, Sacks R, Zanation AM. Endoscopic skull base reconstruction of large dural defects: a systematic review of published evidence. Laryngoscope 2012;122:452-9.
75. Patel MR, Taylor RJ, Hackman TG, et al. Beyond the nasoseptal flap: outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction. Laryngoscope 2014;124:846-52.
76. Germani RM, Vivero R, Herzallah IR, Casiano RR. Endoscopic reconstruction of large anterior skull base defects using acellular dermal allograft. Am J Rhinol 2007;21:615-8.
77. de Almeida JR, Carvalho F, Vaz Guimaraes Filho F, et al. Comparison of endoscopic endonasal and bifrontal craniotomy approaches for olfactory groove meningiomas: a matched pair analysis of outcomes and frontal lobe changes on MRI. J Clin Neurosci 2015;22:1733-41.
78. Stamm AC, Vellutini E, Harvey RJ, Nogeira JF Jr, Herman DR. Endoscopic transnasal craniotomy and the resection of craniopharyngioma. Laryngoscope 2008;118:1142-8.
79. Abergel A, Cavel O, Margalit N, Fliss DM, Gil Z. Comparison of quality of life after transnasal endoscopic vs open skull base tumor resection. Arch Otolaryngol Head Neck Surg 2012;138:142-7.
80. de Almeida JR, Witterick IJ, Vescan AD. Functional outcomes for endoscopic and open skull base surgery: an evidence-based review. Otolaryngol Clin North Am 2011;44:1185-200.
81. Eloy JA, Vivero RJ, Hoang K, et al. Comparison of transnasal endoscopic and open craniofacial resection for malignant tumors of the anterior skull base. Laryngoscope 2009;119:834-40.
82. Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg 2014;140:1124-9.
83. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276-80.
84. Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope 2009;119:1412-6.
85. Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol Ital 2008;28:292-7.
86. Gruber G, Laedrach K, Baumert B, Caversaccio M, Raveh J, Greiner R. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Int J Radiat Oncol Biol Phys 2002;54:486-91.
87. Platek ME, Merzianu M, Mashtare TL, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol 2011;6:41.
88. Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 2016;24:63-9.
89. Herr MW, Sethi RK, Meier JC, et al. Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base 2014;75:58-64.
90. Tajudeen BA, Arshi A, Suh JD, et al. Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull Base 2015;76:43-9.
91. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg 2006;132:134-8.
92. Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck 2017;39:1671-9.
93. Porter AB, Bernold DM, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol 2008;90:201-4.
94. Lucas JT Jr, Ladra MM, MacDonald SM, et al. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer 2015;62:1523-8.
95. Eich HT, Müller RP, Micke O, Kocher M, Berthold F, Hero B. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol 2005;181:378-84.
96. Dumont B, Lemelle L, Cordero C, et al. Esthesioneuroblastoma in children, adolescents and young adults. Bull Cancer 2020;107:934-45.
97. Howell MC, Branstetter BF 4th, Snyderman CH. Patterns of regional spread for esthesioneuroblastoma. AJNR Am J Neuroradiol 2011;32:929-33.
98. Noh OK, Lee SW, Yoon SM, et al. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach? Int J Radiat Oncol Biol Phys 2011;79:443-9.
99. Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck 2003;25:529-34.
100. Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck treatment? Int J Radiat Oncol Biol Phys 2011;81:e255-61.
101. Argiris A, Dutra J, Tseke P, Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003;113:155-60.
102. Gore MR, Zanation AM. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg 2009;135:1030-4.
103. Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer 2013;49:1324-34.
104. Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ. Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol 2002;122:215-21.
105. Konuthula N, Iloreta AM, Miles B, et al. Prognostic significance of Kadish staging in esthesioneuroblastoma: an analysis of the National Cancer Database. Head Neck 2017;39:1962-8.
106. Stokes WA, Camilon PR, Banglawala SM, et al. Is sex an independent prognostic factor in esthesioneuroblastoma? Am J Rhinol Allergy 2015;29:369-72.
107. Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: the princess margaret hospital experience. Head Neck 2008;30:1607-14.
108. Diaz EM Jr, Johnigan RH 3rd, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005;27:138-49.
109. Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med 2012;53:1200-6.
110. Palmieri DE, Tadokoro KS, Valappil B, et al. DOTATATE PET imaging in olfactory neuroblastoma and association with SSTR expression. J Neurol Surg B Skull Base 2024;85:439-44.
111. Dadgar H, Norouzbeigi N, Ahmadzadehfar H, Assadi M. 68Ga-DOTATATE and 18F-FDG PET/CT for the management of esthesioneuroblastoma of the sphenoclival region. Clin Nucl Med 2020;45:e363-4.
112. Classe M, Yao H, Mouawad R, et al. Integrated multi-omic analysis of esthesioneuroblastomas identifies two subgroups linked to cell ontogeny. Cell Rep 2018;25:811-21.e5.
113. Zunitch MJ, Fisch AS, Lin B, et al. Molecular evidence for olfactory neuroblastoma as a tumor of malignant globose basal cells. Mod Pathol 2023;36:100122.
114. Finlay JB, Ireland AS, Hawgood SB, et al. Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer. Cancer Cell 2024;42:1086-105.e13.
115. Hasan OK, Ravi Kumar AS, Kong G, et al. Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma. J Nucl Med 2020;61:1326-30.
116. London NR Jr, Rooper LM, Bishop JA, et al. Expression of programmed cell death ligand 1 and associated lymphocyte infiltration in olfactory neuroblastoma. World Neurosurg 2020;135:e187-93.
117. Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory Neuroblastoma (BARON). Available from: https://classic.clinicaltrials.gov/show/NCT05012098. [Last accessed on 31 Oct 2024].
